Trambauer, Johannes
Sarmiento, Rosa Maria Rodriguez
Garringer, Holly J.
Salbaum, Katja
Pedro, Liliana D.
Crusius, Dennis
Vidal, Ruben
Ghetti, Bernardino
Paquet, Dominik
Baumann, Karlheinz
Lindemann, Lothar
Steiner, Harald
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2145 SyNergy – ID 390857198, 263531414 / FOR2290)
BrightFocus Foundation (ADR AD2019604S)
Ludwig-Maximilians-Universität München
Article History
Received: 11 December 2024
Accepted: 20 January 2025
First Online: 19 February 2025
Change Date: 17 April 2025
Change Type: Update
Change Details: The original version of this article was revised to load the missing Supplementary file 14 e-file: the e-files in the Supplementary Information section were out of sync resulting in the missing Supplementary material 14 e-file.
Change Date: 15 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13195-025-01723-9
Declarations
:
: All experiments were performed in accordance with all relevant guidelines and regulations. Female iPSC line A18944 was purchased from ThermoFisher (A18945). No human subjects were involved in this study; confirmation of consent was not necessary.
: Not applicable.
: H.S. has received research funding from Roche. D.P. is a scientific advisor of ISAR Bioscience. R.M.R.S., K.B., and L.L. are full-time employees of F. Hoffmann-La Roche AG, are inventors of patents in the name of F. Hoffmann-La Roche AG, and might own stocks / stock options of F. Hoffmann-La Roche AG. All other authors declare that they have no conflict of interest.